Responding to dynamic global threats, vaccines for emerging and re-emerging infectious diseases focus on pathogens with epidemic potential such as Ebola, Nipah, and chikungunya. These diseases often surface in vulnerable regions where healthcare infrastructure is limited. Rapid vaccine design, field-ready delivery, and regulatory harmonization are central to mitigating outbreaks. Technological platforms like mRNA, VLPs, and viral vectors are being deployed for speed and adaptability. Cross-sector collaboration is vital to preclinical pipelines, clinical trials, and emergency use readiness. As the frequency of zoonotic spillover rises, vaccines for emerging and re-emerging infectious diseases represent critical investments in pandemic preparedness and global security.
Submit your abstract Today
Title : Emerging nanovaccine strategies for enhanced immune targeting and vaccine performance
Aysel Sadayli, V.Y. Axundov Scientific-Research Institute of Medical Prophylaxis, Azerbaijan
Title : Reaching zero-dose children through adaptive immunization strategies in security-compromised areas of Zamfara State, Nigeria
Attahir Abubakar, Ahmadu Bello University, Nigeria
Title : Advancing vaccine availability and equity in low-resource settings: Evidence from Awendo Sub-County, Kenya
Millicent Ochieng, Clinton Health Access Initiative, Kenya